Business Segments · Goodwill, impairment loss
MedSurg and Neurotechnology — Goodwill, impairment loss
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ4 2024
How to read this metric
An increase signals a decline in the perceived long-term value of the segment's assets, while a zero value indicates that asset valuations remain supported by expected future cash flows.
Detailed definition
This metric represents the write-down of the carrying value of goodwill associated with the MedSurg and Neurotechnology...
Peer comparison
Similar to 'goodwill impairment' charges reported by any large-cap company that engages in frequent M&A activity.
Metric ID:
syk_segment_medsurg_and_neurotechnology_goodwill_impairment_lossHistorical Data
2 years
| FY'22 | FY'24 | |
|---|---|---|
| Value | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's medsurg and neurotechnology — goodwill, impairment loss?
- Stryker (SYK) reported medsurg and neurotechnology — goodwill, impairment loss of $0.00 in Q4 2024.
- What does medsurg and neurotechnology — goodwill, impairment loss mean?
- A non-cash charge recorded when the value of acquired assets in the segment is deemed to be lower than their recorded book value.